NASDAQ : OM

Outset Medical, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 4.19 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 78.76M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Outset Medical, Inc. (OM) reported revenue of 117.80M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue117.80M119.48M113.69M130.38M115.38M102.60M
Cost of Revenue68.61M72.72M74.55M101.25M97.54M94.99M
Gross Profit49.20M46.75M39.14M29.13M17.83M7.61M
Selling, General & Admin93.78M92.27M110.67M139.80M130.00M101.39M
Research & Development21.46M21.20M36.29M56.57M48.85M36.74M
Operating Expenses115.24M113.47M146.96M196.37M178.85M138.13M
Operating Income-66.05M-66.71M-107.82M-167.24M-161.02M-130.52M
Interest Expense-13.73M-13.95M-23.87M-12.68M-3.57M-1.72M
Interest & Investment Income6.41M7.41M9.76M10.17M3.29M498.00K
EBT Excluding Unusual Items-73.36M-73.26M-121.93M-169.74M-161.29M-131.74M
Merger & Restructuring Charges8.00K8.00K-5.55M-2.53M
Other Unusual Items-7.68M-1.37M
Pretax Income-73.36M-80.94M-127.48M-172.27M-162.66M-131.74M
Income Tax Expense936.00K718.00K491.00K523.00K295.00K199.00K
Earnings From Continuing Operations-81.65M-127.98M-172.80M-162.96M-131.94M
Net Income-74.29M-81.65M-127.98M-172.80M-162.96M-131.94M
Net Income to Common-74.29M-81.65M-127.98M-172.80M-162.96M-131.94M
Shares Outstanding (Basic)18.25M15.21M3.46M3.31M3.21M3.04M
Shares Outstanding (Diluted)18.25M15.21M3.46M3.31M3.21M3.04M
EPS (Basic)-4.07-5.37-36.96-52.28-50.75-43.41
EPS (Diluted)-4.07-5.37-36.96-52.28-50.75-43.41
Free Cash Flow-38.88M-47.12M-117.22M-134.81M-154.05M-133.37M
Free Cash Flow Per Share-2.13-3.10-33.85-40.79-47.98-43.88
Gross Margin41.76%39.13%34.43%22.34%15.46%7.41%
Operating Margin-56.06%-55.84%-94.84%-128.27%-139.56%-127.21%
Profit Margin-63.06%-68.34%-112.57%-132.54%-141.24%-128.59%
Free Cash Flow Margin-33.00%-39.44%-103.10%-103.40%-133.53%-129.99%
EBITDA-62.73M-62.37M-102.09M-161.43M-155.85M-125.36M
EBITDA Margin-53.25%-52.20%-89.80%-123.82%-135.08%-122.18%
D&A For EBITDA3.31M4.34M5.73M5.81M5.17M5.16M
EBIT-66.05M-66.71M-107.82M-167.24M-161.02M-130.52M
EBIT Margin-56.06%-55.84%-94.84%-128.27%-139.56%-127.21%
Revenue as Reported117.80M119.48M113.69M130.38M115.38M102.60M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents35.01M35.01M124.01M68.51M73.22M182.35M
Short-Term Investments112.19M133.94M34.67M134.81M214.28M157.14M
Cash & Short-Term Investments147.19M168.95M158.69M203.32M287.50M339.49M
Receivables29.22M28.33M35.62M32.98M28.07M25.60M
Inventory47.31M47.61M59.39M49.22M51.48M39.19M
Prepaid Expenses4.12M6.00M4.53M5.70M6.60M5.53M
Total Current Assets227.85M250.88M258.22M291.22M373.64M409.80M
Property, Plant & Equipment10.29M9.47M12.07M18.65M21.99M20.20M
Other Long-Term Assets4.24M4.15M5.50M3.93M4.48M33.47M
Total Assets242.38M264.50M275.80M313.80M400.12M463.46M
Accounts Payable4.46M554.00K3.86M5.83M603.00K1.76M
Accrued Expenses15.98M16.10M21.94M26.70M30.64M34.72M
Current Portion of Leases2.59M1.74M1.80M1.59M1.32M1.15M
Current Unearned Revenue14.04M13.79M12.75M11.73M8.66M6.34M
Other Current Liabilities6.82M5.44M5.03M9.47M10.73M7.72M
Total Current Liabilities43.89M37.63M45.38M55.32M51.95M51.70M
Long-Term Debt97.65M96.24M197.38M130.11M96.34M29.76M
Long-Term Leases4.21M3.27M2.68M4.48M5.58M6.89M
Long-Term Unearned Revenue302.00K406.00K844.00K101.00K151.00K312.00K
Other Long-Term Liabilities2.69M896.00K113.00K721.00K
Total Liabilities146.05M137.54M248.98M190.91M154.12M89.38M
Common Stock19.00K18.00K4.00K50.00K48.00K47.00K
Additional Paid-In Capital1.30B1.30B1.12B1.08B1.04B1.00B
Retained Earnings-1.21B-1.17B-1.09B-961.75M-788.95M-625.99M
Comprehensive Income & Other-136.00K172.00K42.00K68.00K-564.00K-184.00K
Total Common Equity96.34M126.95M26.82M122.89M245.99M374.08M
Shareholders' Equity96.34M126.95M26.82M122.89M245.99M374.08M
Total Liabilities & Equity242.38M264.50M275.80M313.80M400.12M463.46M
Total Debt104.45M101.25M201.86M136.19M103.23M37.81M
Net Cash (Debt)42.74M67.70M-43.17M67.14M184.27M301.68M
Net Cash Per Share2.344.45-12.4720.3157.3999.26
Filing Date Shares Outstanding18.80M18.31M3.59M3.37M3.24M3.16M
Total Common Shares Outstanding18.80M18.17M3.53M3.35M3.23M3.15M
Working Capital183.96M213.25M212.84M235.90M321.70M358.11M
Book Value Per Share5.136.997.6036.6376.13118.78
Tangible Book Value96.34M126.95M26.82M122.89M245.99M374.08M
Tangible Book Value Per Share5.136.997.6036.6376.13118.78
Machinery19.47M18.60M18.73M16.16M12.47M
Construction In Progress523.00K637.00K769.00K4.77M874.00K
Leasehold Improvements9.58M9.69M9.62M5.04M4.86M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-74.29M-81.65M-127.98M-172.80M-162.96M-131.94M
Depreciation & Amortization3.31M4.34M5.73M5.81M5.17M5.16M
Loss (Gain) From Sale of Assets3.00K5.00K53.00K106.00K39.00K
Loss (Gain) From Sale of Investments-2.02M-2.25M-4.72M-6.37M449.00K1.97M
Stock-Based Compensation15.29M15.62M29.36M38.63M27.20M17.45M
Provision & Write-off of Bad Debts2.63M3.52M2.37M184.00K
Other Operating Activities4.57M11.90M4.57M3.83M5.47M2.69M
Change in Accounts Receivable3.04M3.77M-5.01M-5.09M-2.51M-19.14M
Change in Inventory4.59M11.79M-10.86M1.65M-14.73M-22.04M
Change in Accounts Payable3.04M-3.29M-1.95M5.31M-1.28M-3.07M
Change in Unearned Revenue-251.00K604.00K1.77M3.02M2.16M2.88M
Change in Other Net Operating Assets1.76M-10.68M-9.64M-5.65M-4.79M15.76M
Operating Cash Flow-38.32M-46.33M-116.30M-131.37M-145.73M-130.26M
Capital Expenditures-559.00K-798.00K-912.00K-3.44M-8.32M-3.11M
Investment in Securities34.18M-96.89M104.85M86.47M-57.97M-139.40M
Investing Cash Flow33.62M-97.68M103.94M83.03M-66.30M-142.51M
Long-Term Debt Issued98.27M66.52M33.23M96.06M
Long-Term Debt Repaid-204.95M-31.20M
Net Debt Issued (Repaid)-93.00K-106.68M66.52M33.23M64.86M
Issuance of Common Stock737.00K639.00K2.28M10.43M8.04M160.15M
Other Financing Activities-938.00K
Financing Cash Flow644.00K55.50M67.87M43.65M72.90M160.15M
Net Cash Flow-4.05M-88.51M55.51M-4.70M-139.13M-112.62M
Free Cash Flow-38.88M-47.12M-117.22M-134.81M-154.05M-133.37M
Free Cash Flow Margin-33.00%-39.44%-103.10%-103.40%-133.53%-129.99%
Free Cash Flow Per Share-2.13-3.10-33.85-40.79-47.98-43.88
Levered Free Cash Flow-14.68M-21.35M-69.93M-70.09M-94.56M-87.69M
Unlevered Free Cash Flow-6.10M-12.63M-55.01M-62.17M-92.33M-86.61M
Cash Interest Paid10.87M15.63M20.68M10.85M3.19M1.15M
Cash Income Tax Paid905.00K447.00K593.00K491.00K385.00K83.00K
Change in Working Capital12.19M2.20M-25.69M-773.00K-21.14M-25.60M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization75.75M67.35M58.32M271.61M1.25B2.17B
Enterprise Value33.01M-8.77M84.77M180.84M1.06B1.84B
Last Close Price4.033.7116.6581.15387.30691.35
PS Ratio0.640.560.512.0810.8121.16
PB Ratio0.790.532.172.215.075.80
P/TBV Ratio0.790.532.172.215.075.80
EV/Sales Ratio0.280.751.399.1617.89
Debt / Equity Ratio1.080.807.531.110.420.10
Net Debt / Equity Ratio-0.44-0.531.61-0.55-0.75-0.81
Net Debt / EBITDA Ratio0.681.08-0.420.421.182.41
Net Debt / FCF Ratio1.101.44-0.370.501.202.26
Asset Turnover0.440.440.390.360.270.24
Inventory Turnover1.381.361.372.012.153.30
Quick Ratio4.025.244.284.276.087.06
Current Ratio5.196.675.695.267.197.93
Return on Equity (ROE)-59.17%-106.20%-170.97%-93.69%-52.56%-37.55%
Return on Assets (ROA)-15.54%-15.43%-22.86%-29.28%-23.31%-18.81%
Return on Capital Employed (ROCE)-33.30%-29.40%-46.80%-64.70%-46.20%-31.70%
Earnings Yield-101.02%-121.24%-219.43%-63.62%-13.06%-6.08%
FCF Yield-51.32%-69.97%-200.98%-49.63%-12.35%-6.14%
Buyback Yield / Dilution-129.26%-339.24%-4.78%-2.94%-5.64%-178.69%